- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Enimmune Corp (6564)
Track today's live Enimmune (6564) share price, performance and key data on this page with our current TPEX:6564 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Enimmune share price on the TPEX exchange. Use the dropdown to switch exchange for the 6564 share price, head to our technical summary section, which provides analysis on Enimmune share price buy/sell indicators using real-time data (or discuss the Enimmune (6564) stock price today with other investors in the Enimmune TWO share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TWO:6564 share price (ISIN: TW0006564008) to enhance your trading decisions with our free investment tools and resources.
What Is the Enimmune Corp Share Price Today?
The Enimmune share price today is 14.90.
What Is the Stock Symbol for Enimmune Corp
The stock symbol (or 'ticker') for Enimmune Corp is "6564."
What Stock Exchange Does Enimmune Corp Trade On?
Enimmune Corp is listed and trades on the TPEX stock exchange.
Is Enimmune Corp a Good Stock to Buy?
Determining whether Enimmune (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current TWO:6564 share price (ISIN: TW0006564008) to enhance your trading decisions with our free investment tools and resources.
What Is the Enimmune Corp Share Price Today?
The Enimmune share price today is 14.90.
What Is the Stock Symbol for Enimmune Corp
The stock symbol (or 'ticker') for Enimmune Corp is "6564."
What Stock Exchange Does Enimmune Corp Trade On?
Enimmune Corp is listed and trades on the TPEX stock exchange.
Is Enimmune Corp a Good Stock to Buy?
Determining whether Enimmune (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
TPEX
Currency in TWD
14.90
-0.40(-2.61%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.65
15.25
52 wk Range
14.65
16.05
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.6515.25
52 wk Range
14.6516.05
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
6564 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Currently not supported.
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading near 52-week low
Earnings
Latest Release
12/08/2026
EPS / Forecast
-0.68 / --
Revenue / Forecast
27.9M / --
Compare 6564 to Peers and Sector
Metrics to compare | 6564 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6564PeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.9x | −89.1x | −0.3x | |
PEG Ratio | −0.36 | −9.58 | 0.00 | |
Price/Book | 10.7x | 7.5x | 2.6x | |
Price / LTM Sales | 20.1x | 158.5x | 2.8x | |
Upside (Analyst Target) | - | 0.0% | 66.6% | |
Fair Value Upside | Unlock | −27.9% | 9.1% | Unlock |
Enimmune Corporation engages in the research, development, and sale of drugs in Taiwan. The company offers EnVAX-A71, AimFlu-S(QIS), tetanus vaccine adsorbed suspension for injection, COVID-19 Ag rapid test, vaccines, test reagents, and related western medicines, as well as biotechnology services. It is also involved in the development of vaccines for the prevention of infectious diseases, including pneumococcus, norovirus, dengue fever virus, and Middle East respiratory syndrome, such as cell culture-derived Japanese encephalitis vaccine, which is in pre-clinical stage for the treatment of Japanese encephalitis virus; EV71+CA16 bivalent vaccine, which is in research stage for the treatment of hand-foot-mouth disease caused by Coxsackie A virus and enterovirus 71; and Anti-RBD monoclonal antibody, a murine monoclonal antibody for the recognition of receptor binding domain of the SARS-CoV-2 spike protein. The company was founded in 2014 and is based in Taipei, Taiwan. Enimmune Corporation is a subsidiary of Adimmune Corporation.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Enimmune (TPEX: 6564) Share Price Today?
The Enimmune stock price today is 14.90 TWD.
What Stock Exchange Does Enimmune (6564) Trade On?
Enimmune is listed and trades on the Taipei Exchange.
What Is the Ticker (Stock Symbol) for Enimmune?
The stock symbol (also called a 'ticker') for Enimmune is "6564."
What Is the Current Enimmune Market Capitalisation?
As of today, Enimmune (TPEX: 6564) market cap is 1.15B TWD.
What Is Enimmune's (6564) Earnings Per Share (TTM)?
The Enimmune EPS is currently -1.68 (Trailing Twelve Months).
How Many Times Has Enimmune Stock Split?
Enimmune has split 0 times. (See the 6564 stock split history page for full effective split date and price information.)
What is the current trading status of Enimmune (TPEX: 6564)?
As of 31/10/2026, Enimmune (6564) is trading at a share price of 14.90 TWD, with a previous close of 0.00 TWD. The stock has fluctuated within a day range of 14.65 TWD to 15.25 TWD, while its 52-week range spans from 14.65 TWD to 16.05 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.